ORIGINAL RESEARCH
Accepted on 22 Jul 2025
Multinational cost-effectiveness analysis of pembrolizumab combined with chemotherapy as first-line treatment for advanced biliary tract cancer
doi 10.3389/fpubh.2025.1597550
- Frontiers in Public Health
- Health Economics
- Research Topics
- Immunization Economics: Balancing Costs, Outcomes, and Equity in Public Health
Immunization Economics: Balancing Costs, Outcomes, and Equity in Public Health
617
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.